Morphine Sulfate Extended-Release Tablets, 100 mg, 100-count bottles, Rx Only, Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873 Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202 NDC 43386-543-01
Published May 1, 2019 · Recall initiated: April 10, 2019
Summary
FDA records drug Class III recall D-1246-2019, published May 1, 2019 and initiated April 10, 2019. Recalling firm: LUPIN SOMERSET; Status: Terminated; Reported quantity: 3,444 bottles; Lot: Lot#: S700223 Exp. Apr 30 2019; S800467, Exp. Mar 31 2020. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications
What to do
Voluntary: Firm initiated · Letter
Get an email if MORPHINE SULFATE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- MORPHINE SULFATE
- Manufacturer
- LUPIN SOMERSET
- Distributor
- Product was shipped to 5 wholesalers and one Supermarket Chain who may have further distributed the product throughout the United States.
- UPC
- 0343386542017
- Lot
- Lot#: S700223 Exp. Apr 30 2019; S800467, Exp. Mar 31 2020.
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAMorphine Sulfate Injection, USP, 2 mg /mL, 1 mL single-dose Simplist prefilled syringes, For Intramuscular orAugust 26, 2026
- FDAMorphine Sulfate Oral Solution 100 mg / 5 mL (20 mg* / mL), 30 mL, Rx Only, For Oral Use Only, ManufacturedDecember 17, 2025
- FDAMorphine Sulfate Extended-Release Tablets, 100 mg, 100-count bottles, Rx Only, Manufactured by: OhmMarch 12, 2025
- FDAMorphine Sulfate Injection, USP, 2 mg per mL, 1 mL single dose vial, Rx only, Fresenius Kabi, Lake Zurich, ILOctober 6, 2021
- FDAMorphine Sulfate Extended-Release Tablets, 60 mg, 100-count bottles, Rx Only, Manufactured by: NovelMay 1, 2019
- FDAMorphine Sulfate Extended-Release Tablets, 200 mg Rx Only 100 Tablets Manufactured by: Novel Laboratories,May 1, 2019
Questions about this recall
Was Morphine Sulfate Extended-Release Tablets, 100 mg, 100-count bottles, Rx Only, Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873 Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202 NDC 43386-543-01 recalled?
Yes. FDA published recall D-1246-2019 on May 1, 2019. Reported hazard: Failed Impurities/Degradation Specifications
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: MORPHINE SULFATE. UPC: 0343386542017.